Patient guide
GLP-1 medicines: common myths and what the evidence says
Social media and word of mouth have produced many confident claims about GLP-1 medicines. Some are accurate, some are partly true and some are wrong. This guide takes the common ones in turn and states how strong the evidence is.
Last checked: 2026-10-03
Key facts
At a glance.
-
Not a quick fix
These are long-term treatments for a chronic condition, used with lifestyle support.
-
Safety data
Large trials exist, but very long-term and real-world safety data are still accumulating.
-
Not cosmetic
They are licensed for medical weight management and diabetes, not for small cosmetic weight goals.
-
Individual response
Average trial results hide wide variation between people.
Myth: it is cheating or taking the easy way out
Obesity is influenced by genetics, hormones, sleep, medicines, environment and mental health. Medicines that act on appetite biology treat a physiological driver. Taking one is no more cheating than taking a statin for cholesterol. Prescribers still expect nutrition and activity support alongside it, because the medicine does not replace them.
Myth: it only works because you eat very little
Appetite reduction is the main mechanism, and people do eat less. The medicine changes how hungry and full you feel, making smaller portions easier. Eating too little is a real risk, though, and is one reason follow-up with nutrition advice is important.
Myth: you can stop once you reach your goal and keep the loss
Trial data suggest that weight typically returns towards baseline after treatment is withdrawn. Some people maintain more than others, particularly with continued habit change. This is why planning for maintenance matters.
Myth: it causes permanent damage to the pancreas or stomach
Pancreatitis and gallbladder disease are recognised, uncommon risks, and the MHRA has asked people to report suspected side effects and has been reviewing pancreatitis reports. The vast majority of people do not develop these problems, but anyone with severe abdominal pain should seek urgent care. The claim of widespread permanent damage is not supported by the evidence reviewed so far, though long-term monitoring continues.
Myth: "Ozempic face" is a drug side effect
Facial thinning that some people notice is generally a consequence of losing fat quickly, as seen with any rapid weight loss, rather than a specific action of the drug. Older people may find that it makes the face look more lined or hollow. It is a cosmetic effect, not a medical complication.
Myth: compounded or research-grade versions are the same thing
Licensed medicines are manufactured to approved standards and monitored for safety. Products sold online as peptides, research chemicals or compounded versions are not licensed in the UK for human use in this way, and the MHRA has warned about them. They can differ in strength and purity.
Myth: they are safe for everyone
They are not suitable in pregnancy or breastfeeding, require caution with a history of pancreatitis or certain thyroid cancers, and need careful consideration with a history of eating disorders, severe gastrointestinal disease or advanced kidney disease. This is why assessment matters.
Frequently asked
Questions people ask.
Quick, plain-English answers to the questions we hear most.
-
Do these medicines work for everyone?
No. Trials show a wide range of responses, and some people lose little weight.
-
Do they cause thyroid cancer?
Animal studies showed thyroid tumours in rodents, and product information advises caution with certain family histories. Human evidence has not confirmed a risk, but monitoring continues.
-
Is it fine to use them to lose a few kilos?
They are licensed for people with a defined BMI and health need. Use below those thresholds is outside the licence, and risks may outweigh benefits.
-
Can they affect fertility?
Weight loss can improve ovulation, which can make pregnancy more likely, and the medicines are not recommended during pregnancy, so contraception planning matters.
-
Are the injections painful?
The needles are very fine and most people find them tolerable. Technique is shown at start.
-
Do they cause hair loss?
Hair shedding can follow rapid weight loss from any cause. It is generally temporary.
-
Is it true that you cannot drink alcohol?
There is no absolute ban, but many people find alcohol less appealing or more nauseating, and alcohol adds calories and stress to the liver.
-
Are there any long-term safety data?
Trials have followed people for a few years, and diabetes versions have been used longer. Longer-term monitoring is continuing.
Where this comes from
Sources and checking.
This guide is for information, not medical advice.
Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.
Published 2026-10-03, next review 2027-10-03.
-
MHRA drug safety updates and Yellow Card scheme information (gov.uk/mhra)
-
NICE guideline NG246, Overweight and obesity management (nice.org.uk)
-
NHS website, Obesity and weight-loss medicines pages (nhs.uk)
-
NICE technology appraisal TA1026, Tirzepatide for managing overweight and obesity (nice.org.uk)